Overview
Excited to announce the upcoming Regenerative Medicine & Aesthetic Medicine edition for Morning Pitch Asia @Singapore on 26th March, 2026.
Regenerative & Aesthetic Medicine refers to the use of advanced biological technologies to restore, repair, or enhance tissues and organs for both therapeutic and cosmetic purposes.
Morning Pitch is the pitching platform hosted by Deloitte where we aim to create collaborations between Asian large size corporations/investors and startups.
The event series was originally launched in Japan in 2013, where it has been organized over 500 times, over 2,450 startups have pitched, and more than 65 IPOs and 475+ business alliances have been created.
Venue:
In-person*: SGInnovate(32 CARPENTER STREET Singapore 059911)
Online: Zoom Webinar
*Due to limitation of capacity on the venue, it would be first-come-first-served basis.
*Registration is until 9:00SGT/10:00JST on the day.
Pitching Startups:
Coming soon...
Privacy Notice:
Deloitte is a privacy conscious global organization. We will treat the information we collect from you as a result of your registration and participation for this event in accordance with our Privacy Policy, which is located at https://www2.deloitte.com/jp/ja/legal/privacy.html / https://www2.deloitte.com/sg/en/legal/privacy.html
Schedule
Date: 26 Mar 2026, Thursday
Time: 6:00 PM - 7:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: 32 Carpenter Street, 059911 and Online
Speakers
Moderator's Profile:
Gempei Asama, Head of ASEAN Region, Deloitte Tohmatsu Venture Support
Gempei is Head of ASEAN Region in Deloitte Tohmatsu Venture Support. He is leading Morning Pitch Asia, which aims to create innovative new businesses between startups and large corporations or investors across the Asia Pacific. His expertise is finance and he has a lot of experience in helping startups get funding and expand their footprints into other regions to scale up. He has been supporting a government agency to promote open innovation between ASEAN startups and MNCs in Singapore. Before moving to Singapore, he launched multiple startup supporting programs in Tokyo, Japan, and help quite a few startups from seed to growth stage using his financial expertise. Besides, he was engaged in corporate venturing activity such as building corporate venture capital arms or running acceleration programs with Japanese large corporations.
Moderator's Profile:
Marisa Yamamoto, Consultant, Deloitte Tohmatsu Venture Support
Marisa has been instrumental in driving innovation ecosystems at Deloitte Tohmatsu Venture Support, both domestically and internationally. She has provided hands-on support to startups, led new business development initiatives for large enterprises, and facilitated efforts toward global expansion. Her experience at the Ministry of Foreign Affairs equipped her with expertise in policy development and intergovernmental coordination, as she successfully led discussions and negotiations on Japan's potential participation in Horizon Europe, the European international joint research framework. In addition, Marisa served as the Science Attaché at the Japanese Consulate General in Boston during the COVID-19 pandemic. There, she conducted extensive research on life sciences innovation, further strengthening her credentials in science policy and international collaboration.
